»ó´Ü¿©¹é
±â»ç (Àüü 23°Ç)
[Cover Story] Çö´ëÀÇÇÐÀÌ Á÷¸éÇÑ ÃÖ´ëÀÇ Ç÷Àü ÀÌ»óµ· ±âÀÚ 2022-12-06 12:33
[Sub Story] ³úÁ¹Áß ¿¹¹æ¿¡ ½Ç·Î½ºÅ¸Á¹ DAPT ¼º°øÀû ÀÌ»óµ· ±âÀÚ 2022-12-06 12:26
[Sub Story] °íÇ÷¾Ð¡¤ÀÌ»óÁöÁúÇ÷Áõ¡¤´ç´¢º´ ÀÌ»óµ· ±âÀÚ 2022-12-06 12:26
[Sub Story] ¾Æ½Ã¾ÆÀΡ¤À¯Áõ»ó¡¤ÁøÇ༺ ICAS µ¿¹Ý ³úÁ¹Áß ¿¹¹æÀü·«Àº? ÀÌ»óµ· ±âÀÚ 2022-12-06 12:16
[Sub Story] ÁýÁß Ç÷¾ÐÁ¶Àý·Î ³úÁ¹Áß¡¤Ä¡¸Å ¸·´Â´Ù ÀÌ»óµ· ±âÀÚ 2022-12-06 11:38
¶óÀÎ
[Sub Story] ½ºÅ¸Æ¾ ´Üµ¶¡¤ºñ½ºÅ¸Æ¾°è º´¿ë ³úÁ¹Áß ¿¹¹æÇýÅà ½Ã»ç ÀÌ»óµ· ±âÀÚ 2022-12-06 11:34
[Sub Story] ¹«»ç°í DAPT ÈÄ ´Üµ¶Àüȯ Ŭ·ÎÇǵµ±×·¼ vs ¾Æ½ºÇǸ° ÀÌ»óµ· ±âÀÚ 2022-12-06 11:20
[Sub Story] 6³â°üÂû¿¡¼­µµ Ŭ·ÎÇǵµ±×·¼ ½Â¸® ±»È÷±â ÀÌ»óµ· ±âÀÚ 2022-12-06 11:15
[Sub Story] ´ëÇ÷°üÇÕº´Áõ ¿¹¹æ À§ÇÑ Ç÷¾Ð¡¤ÁöÁú¡¤Ç÷Àü¡¤Ç÷´ç Á¾ÇÕÄ¡·á Àü·« ÀÌ»óµ· ±âÀÚ 2022-12-06 11:05
[Sub Story] NOAC ³úÁ¹Áß ¿¹¹æÇýÅà £¾ ÃâÇ÷À§Çè ÀÓ¼¼Çü ±âÀÚ 2022-12-06 10:58
¶óÀÎ
[Deep in Guideline] SGLT-2¾ïÁ¦Á¦ ½ÉºÎÀü Ä¡·áÁ¦·Î Àü¸é¿¡ ÀÓ¼¼Çü ±âÀÚ 2022-12-06 10:44
[The Rare Disease] PHEX À¯ÀüÀÚ ¿øÀÎ Àλ꿰 °áÇÌ °ñÁúȯ ÀÓ¼¼Çü ±âÀÚ 2022-12-06 10:36
[The Rare Disease] 1¼¼ ÀÌ»ó XLH ȯÀÚ ÇÙ½É Ä¡·áÀü·« ÀÓ¼¼Çü ±âÀÚ 2022-12-06 10:36
[Primary Expert Opinion] [1Â÷ ÀÇ·á±â°ü ½ÃÁ¡ÀÇ ½É¹æ¼¼µ¿ °ü¸®Àü·«]

¡°ÀÌÁ¦´Â 1Â÷ÀÇ·á¿¡¼­ Àû±ØÀûÀ¸·Î ½É¹æ¼¼µ¿À» °ü¸®ÇØ¾ß ÇÑ´Ù¡±
THE MOST 2022-12-05 15:55
[Conference Report] EASD 2022: ADA/EASD Consensus Report & UKPDS THE MOST 2022-12-05 15:14
¶óÀÎ
[Late Breaking Studies] ¾Æ½Ã¾ÆÀÎ Ç÷´ç°­ÇÏÁ¦ ó¹æ ºÐ¼®Çغ¸´Ï ÀÌ»óµ· ±âÀÚ 2022-12-05 15:03
[Interview] ¾Æ½Ã¾ÆÀÎ 2Çü´ç´¢º´¿¡¼­ ¼³Æù¿ä¼ÒÁ¦ ºñÁß¡¤¿ªÇÒ °ÇÀç ÀÌ»óµ· ±âÀÚ 2022-12-05 14:55
[Conference Report] ¡°S-¾Ï·ÎµðÇÉÀ¸·Î ÇÏÁöºÎÁ¾ ±Øº¹¡± ÀÓ¼¼Çü ±âÀÚ 2022-12-05 14:51
[Conference Report] ´ëÇÑ°íÇ÷¾ÐÇÐȸ 2022³â °íÇ÷¾Ð Áø·áÁöħ °ø°³ ÀÓ¼¼Çü ±âÀÚ 2022-12-05 14:47
[Conference Report] ÇǸ¶»ç¸£Åº/½ºÅ¸Æ¾ SPC À¯È¿¼º¿¡ ³»¾à¼º¡¤¼øÀÀµµ±îÁö¡è ÀÌ»óµ· ±âÀÚ 2022-12-05 14:39
Back to Top